Answer-first peptide reference
How to Verify Peptide COA Raw Data
Check peptide COA raw data by reviewing HPLC chromatograms, LC-MS spectra, lot traceability, content basis, salt form and RUO documentation.
Answer first: a peptide COA is only credible when the raw analytical evidence matches the lot being sold. A clean PDF number is not enough. The minimum review is HPLC chromatogram plus integration table, LC-MS or HRMS spectrum, lot number, sample preparation, method conditions, salt form, water or counterion statement, and a Research Use Only boundary. If any of those are missing, treat the COA as a marketing sheet until the supplier provides the underlying data.
Start with lot traceability, not the purity number
The first check is whether the document belongs to the material in front of you. Match product name, sequence, modification, lot number, vial label, manufacturing date, retest date and supplier name. Many weak COAs fail before the analytical review begins: a screenshot has no lot number, the chromatogram date is older than the stated batch, or the same LC-MS image appears under different product names. For custom peptides, confirm terminal modifications, disulfide bridges, lipid chains, dye labels or PEG/DAC conjugation in the ordered structure. If the label says Semaglutide but the file only says "GLP-1 analog," the record is too loose for procurement review.
- Lot number must appear on label, invoice and COA
- Ordered sequence must match the tested sequence
- Modification names must be written, not implied
- Test date should be plausible for the batch release date
Read HPLC as one method, not the full truth
HPLC area purity is useful, but it is not peptide content and not identity proof. A UV chromatogram at 214 nm may detect peptide bonds strongly while underrepresenting non-UV impurities; a different wavelength may change apparent purity. Integration can also hide shoulders, fronting, late-eluting hydrophobic impurities or solvent baseline drift. Ask for the gradient, column, mobile phase, detection wavelength, injection amount and integration table. A supplier who refuses to share method basics is asking the buyer to trust a number without context. For lipidated GLP-1 peptides, hydrophobic carryover and broad peaks deserve extra attention.
- Reported value: area percent under stated HPLC method
- Not equal to: assay, peptide content or mass balance
- Method fields: column, gradient, wavelength, flow, injection, integration
- Red flag: cropped chromatogram with no retention-time scale
LC-MS should answer the identity question
Mass data should show the expected charge-state envelope, deconvoluted mass or accurate m/z assignment for the peptide form being sold. For shorter peptides, single-charge ions may be clear; for larger or modified peptides, multiple charge states and adducts are normal. The review question is simple: does the observed mass correspond to the declared sequence, salt-free neutral form or specific modified form? A vague "MS conforms" line is weak. For isobaric residues such as Leu/Ile, routine LC-MS still cannot prove the exact side-chain identity without specialized fragmentation or reference comparison, so the limitation should be stated rather than hidden.
- Confirm expected mass basis: neutral, protonated or deconvoluted
- Check adducts: sodium, potassium, TFA or acetate can complicate spectra
- Require modification evidence for lipid, dye, amidation or disulfide claims
- Record limitation: routine MS may not resolve all isomers
Content, salt and water change the usable amount
Two peptide lots can both show 98% HPLC purity and still deliver different net peptide content. TFA salts, acetate salts, sodium salts and residual water all affect the weighed mass. Cosmetic blends may add carriers or buffers; lyophilized RUO vials may include counterions or water that the buyer forgets to account for in research calculations. Do not let a supplier use "purity" as a substitute for content basis. Ask whether the reported amount is gross powder mass, net peptide, peptide acetate, peptide TFA, or assay-corrected content. The answer matters most for quantitative reference standards and blend ratio work.
- Ask for: salt form, counterion estimate, water by KF where relevant
- Ask for: peptide content or assay basis when quantitative use matters
- Watch for: "10 mg" without net peptide statement
- Watch for: cosmetic raw materials diluted into carrier powders
Frequently asked questions
Does HPLC purity prove peptide identity?
No. HPLC area purity describes chromatographic area under one method; identity still needs mass, sequence or modification evidence.
What raw files should I request with a peptide COA?
Ask for the chromatogram, integration table, method, LC-MS spectrum, m/z assignment, lot number, preparation date and content basis.
Why can two COAs show different purity for the same peptide?
Different gradients, wavelengths, salts, counterions, integration settings and sample preparation can change reported area purity.
Internal topic cluster
These internal links connect the answer to COA, counterion, compliance and classification pages so search engines and AI systems can follow the topical cluster instead of treating this page as an isolated note.
Primary records and verification routes
Use the primary paper, regulator page or lot-linked analytical file for the exact claim it supports. A search result is a route to evidence, not evidence by itself.